NurseSavvy™
Log inSign Up
side by side comparison

Antipsychotic Comparison: Typical vs Atypical — EPS Risk vs Metabolic Risk

A client on haloperidol develops a rigid, feverish presentation — is it EPS or NMS? A client on olanzapine gains 30 pounds in three months — expected or reportable? Mixing up which generation carries which risk profile leads you to monitor the wrong thing and miss the real danger.

Master this comparison — play it or drill it.

Practice 20 NCLEX-style questions

Practice now

Comparison

Side-by-side2 compared
Focus
Dimension
Typical (1st-Gen)
Atypical (2nd-Gen)
Class & mechanism
  • D2 dopamine blockade
  • D2 + 5-HT2A serotonin blockade
Indications
  • Haloperidol IM: acute agitation
  • Mainly positive symptoms
  • First-line schizophrenia
  • Bipolar disorder
  • Positive AND negative symptoms
Route & forms
  • Haloperidol/fluphenazine decanoate IM
  • ODT: olanzapine, risperidone
Key assessment
  • Watch for EPS at each visit
  • Baseline AIMS for tardive dyskinesia
  • Baseline weight, BMI, waist
  • Fasting glucose & lipid panel
  • Baseline AIMS for tardive dyskinesia
Monitoring
  • Few routine labs
  • Glucose, lipids, weight on schedule
  • ★Clozapine: monitor ANC/WBC
Adverse effects
  • ★EPS: dystonia, akathisia, parkinsonism
  • Haloperidol: highest EPS risk
  • ★Weight gain, ↑ glucose, ↑ lipids
  • Lower EPS risk
Black box & toxicity
  • Black box: ↑ death in elderly dementia
  • Higher tardive dyskinesia risk
  • Black box: ↑ death in elderly dementia
  • Clozapine: agranulocytosis (boxed)
Cautions & interactions
  • NMS: fever, rigidity, ↑ CK, unstable VS
  • QT prolongation — monitor ECG
  • NMS: fever, rigidity, ↑ CK, unstable VS
  • QT prolongation — monitor ECG
Patient teaching
  • Report fever or muscle rigidity (NMS)
  • Rise slowly
  • Report spasms or restlessness (EPS)
  • Report fever or muscle rigidity (NMS)
  • Diet + exercise for weight gain
  • Report excess thirst or urination
  • Rise slowly
Class & mechanism

Typical (1st-Gen)

  • D2 dopamine blockade

Atypical (2nd-Gen)

  • D2 + 5-HT2A serotonin blockade
Indications

Typical (1st-Gen)

  • Haloperidol IM: acute agitation
  • Mainly positive symptoms

Atypical (2nd-Gen)

  • First-line schizophrenia
  • Bipolar disorder
  • Positive AND negative symptoms
Route & forms

Typical (1st-Gen)

  • Haloperidol/fluphenazine decanoate IM

Atypical (2nd-Gen)

  • ODT: olanzapine, risperidone
Key assessment

Typical (1st-Gen)

  • Watch for EPS at each visit
  • Baseline AIMS for tardive dyskinesia

Atypical (2nd-Gen)

  • Baseline weight, BMI, waist
  • Fasting glucose & lipid panel
  • Baseline AIMS for tardive dyskinesia
Monitoring

Typical (1st-Gen)

  • Few routine labs

Atypical (2nd-Gen)

  • Glucose, lipids, weight on schedule
  • ★Clozapine: monitor ANC/WBC
Adverse effects

Typical (1st-Gen)

  • ★EPS: dystonia, akathisia, parkinsonism
  • Haloperidol: highest EPS risk

Atypical (2nd-Gen)

  • ★Weight gain, ↑ glucose, ↑ lipids
  • Lower EPS risk
Black box & toxicity

Typical (1st-Gen)

  • Black box: ↑ death in elderly dementia
  • Higher tardive dyskinesia risk

Atypical (2nd-Gen)

  • Black box: ↑ death in elderly dementia
  • Clozapine: agranulocytosis (boxed)
Cautions & interactions

Typical (1st-Gen)

  • NMS: fever, rigidity, ↑ CK, unstable VS
  • QT prolongation — monitor ECG

Atypical (2nd-Gen)

  • NMS: fever, rigidity, ↑ CK, unstable VS
  • QT prolongation — monitor ECG
Patient teaching

Typical (1st-Gen)

  • Report fever or muscle rigidity (NMS)
  • Rise slowly
  • Report spasms or restlessness (EPS)

Atypical (2nd-Gen)

  • Report fever or muscle rigidity (NMS)
  • Diet + exercise for weight gain
  • Report excess thirst or urination
  • Rise slowly

★ marks the fact that sets a column apart.

Clinical Pearl

Typicals trap movement (EPS); atypicals trap metabolism (weight, sugar, lipids) — NMS is the emergency for both.

Component Topics

Ready to master this comparison?

Get a personalized study plan built around this topic — free to try, no card needed.